It is likely, however, that CB2 is upregulated in the vasculature in pathologies such as atherosclerosis, where an anti-inflammatory role for CB2 activation has been identified [25], and we recently showed that high glucose or high insulin treatment increases the mRNA of CB2 in endothelial cells [20]. This evidence concerns the gene INS and atherosclerosis.